Life Sciences

FDA warns Victory Pharma for misleading sales aid

Pharma Compliance Alert, December 24, 2008

A Victory Pharma sales aid minimizes risks, presents misleading safety information, and omits important risk information associated with the use of Xodol, according to an FDA warning letter.

According to the FDA, the sales aid also suggests that Xodol is safer and effective for use under broader conditions than has been demonstrated by substantial evidence or substantial clinical experience.

Comments

0 comments on “FDA warns Victory Pharma for misleading sales aid

 

Most Popular

Related Articles